In this community-based HCC screening on an aged population in an HCV-endemic township, we found that platelet count and AFP could be feasible markers for high-risk patient identification and ...

Hepatocellular carcinoma (HCC) is a primary liver malignancy that typically develops in the setting of chronic liver disease. It is the 4th leading cause of cancer Worldwide with a five-year survival ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of cancer-related deaths. Screening efforts for this cancer focus on ...

Genetron Health has developed a blood-based early screening test called HCCscreen™, which is capable of detecting the biological changes that are associated with hepatocellular carcinoma (HCC ...

After further studies and intensive follow up, there were 16 confirmed HCC cases within 1 year after screening. As shown in Table 1, the PPV of AFP was 38.9%, which was much higher than the ...